Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microvascular permeability and venous tone refers to a set of physiological parameters and clinical endpoints rather than a single molecular target such as a receptor or enzyme (Source: PubMed, PMID: 15500339). Microvascular permeability is the capacity of the capillary and post-capillary venule walls to allow the passage of fluids, solutes, and cells, which is often pathologically increased in inflammatory states. Venous tone describes the degree of contraction of the smooth muscle within the venous wall, which is essential for maintaining venous return and preventing blood pooling in the lower extremities (Source: StatPearls, NBK557563). These processes are the primary focus of venoactive drugs, also known as phlebotonics, used to treat chronic venous insufficiency, varicose veins, and hemorrhoids. Drugs like diosmin and hesperidin modulate these parameters by prolonging the effect of noradrenaline on venous smooth muscle and inhibiting the release of inflammatory mediators like prostaglandins and leukotrienes (Source: PubMed, PMID: 11529667). Because this term encompasses broad physiological functions regulated by various receptors and enzymes, it does not represent a single, discrete therapeutic target molecule.
Venoactive drugs typically act by increasing the sensitivity of venous smooth muscle to noradrenaline, inhibiting the degradation of noradrenaline by catechol-O-methyltransferase (COMT), and reducing the activation and adhesion of leukocytes to the vascular endothelium, thereby decreasing the release of inflammatory mediators that increase permeability (Source: PubMed, PMID: 15500339; StatPearls, NBK557563).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microvascular permeability and venous tone.